Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Arenaccio

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Molecular Biotechnology|September 1, 2018
DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and TumorsFlavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini, et al.
Virology|September 13, 2015
The ADAR1 editing enzyme is encapsidated into HIV-1 virionsElisa Orecchini, Maurizio Federico, Margherita Doria, et al.
Journal of Virology|July 25, 2014
Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanismClaudia Arenaccio, Chiara Chiozzini, Sandra Columba-Cabezas, et al.
Virology|February 24, 2015
miR-146a controls CXCR4 expression in a pathway that involves PLZF and can be used to inhibit HIV-1 infection of CD4(+) T lymphocytesMaria Teresa Quaranta, Eleonora Olivetta, Massimo Sanchez, et al.
Vaccines|November 12, 2016
The CD8⁺ T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIX<sup>TM</sup> AdjuvantFrancesco Manfredi, Paola di Bonito, Barbara Ridolfi, et al.
Biotechnology Journal|December 24, 2017
An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral AntigensSimona Anticoli, Francesco Manfredi, Chiara Chiozzini, et al.
BMC Biotechnology|October 19, 2019
Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8<sup>+</sup> T lymphocyte exhaustionAlessandro Ascione, Claudia Arenaccio, Alessandra Mallano, et al.
Archives of Virology|May 6, 2017
Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4<sup>+</sup> T lymphocytes and reactivation of the HIV-1 reservoirChiara Chiozzini, Claudia Arenaccio, Eleonora Olivetta, et al.
International Journal of Nanomedicine|July 12, 2017
Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculationPaola Di Bonito, Chiara Chiozzini, Claudia Arenaccio, et al.
Viruses|March 12, 2015
HPV-E7 delivered by engineered exosomes elicits a protective CD8⁺ T cell-mediated immune responsePaola Di Bonito, Barbara Ridolfi, Sandra Columba-Cabezas, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Molecular Biotechnology|September 1, 2018
DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and TumorsFlavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini, et al.
Virology|September 13, 2015
The ADAR1 editing enzyme is encapsidated into HIV-1 virionsElisa Orecchini, Maurizio Federico, Margherita Doria, et al.
Journal of Virology|July 25, 2014
Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanismClaudia Arenaccio, Chiara Chiozzini, Sandra Columba-Cabezas, et al.
Virology|February 24, 2015
miR-146a controls CXCR4 expression in a pathway that involves PLZF and can be used to inhibit HIV-1 infection of CD4(+) T lymphocytesMaria Teresa Quaranta, Eleonora Olivetta, Massimo Sanchez, et al.
Vaccines|November 12, 2016
The CD8⁺ T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIX<sup>TM</sup> AdjuvantFrancesco Manfredi, Paola di Bonito, Barbara Ridolfi, et al.
Biotechnology Journal|December 24, 2017
An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral AntigensSimona Anticoli, Francesco Manfredi, Chiara Chiozzini, et al.
BMC Biotechnology|October 19, 2019
Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8<sup>+</sup> T lymphocyte exhaustionAlessandro Ascione, Claudia Arenaccio, Alessandra Mallano, et al.
Archives of Virology|May 6, 2017
Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4<sup>+</sup> T lymphocytes and reactivation of the HIV-1 reservoirChiara Chiozzini, Claudia Arenaccio, Eleonora Olivetta, et al.
International Journal of Nanomedicine|July 12, 2017
Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculationPaola Di Bonito, Chiara Chiozzini, Claudia Arenaccio, et al.
Viruses|March 12, 2015
HPV-E7 delivered by engineered exosomes elicits a protective CD8⁺ T cell-mediated immune responsePaola Di Bonito, Barbara Ridolfi, Sandra Columba-Cabezas, et al.
Pageof 3